REFERENCES
- STOUT SE, OWENS MH, NEMEROFF CB: Neurokinin 1 receptor antagonists as potential antidepressants. Ann. Rev. Pharmacol. Toxicol. (2001) 41:877–906.
- ZHANG Y, LU L, FURLONGER C, WU GE, PAIGE CJ: Hemokinin is a hematopeietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. (2000) 1:392–397.
- KIYAMA H MAENO H: The tachykinin system. In: Atlas of Neuroactive substances and their receptors in the rat. Tohyama M, Takatsuji K (Eds) Oxford University Press, Tokyo, Japan. (1998):182-191.
- MORTEAU O LU B GERARD C GERARD NP: Hemokinin is a full agonist at the substance P receptor. Nat. Immunol. (2001) 2:1088.
- PAGE NM BELL NJ GARDINER SM et al.: Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc. Nat. Acad. Sci. USA (2003) 100:6425–6250.
- SARIA A: The tachykinin NK1 receptor in the brain: pharmacology and putative functions. Eur. J. Pharmacol. (1999) 375:51–60.
- GARLAND AM GRADY EF PAYAN DG VIGNA SR BUNNET NW: Agonist-induced internalization of the substance P (NK1) receptor expressed in epithelial cells. Biochem. J. (1994) 303:177–186.
- MUSSAP CJ GERAGHTY DP BURCHER E: Tachykinin receptors: a radioligand binding perspective. J. Neurochem. (1993) 60:1987–2008.
- BELLUCCI F CARINI F CATALANI C et al.: Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br. J. Pharmacol. (2002) 135:266–274.
- DUFFY RA HEDRICK JA COHEN-WILLIAMS ME et al.: Centrally administered hemokinin-1 (HK-1), a neurokinin receptor agonist, produces Substance P-like behavioral effects in mice and gerbils. Neuropharmacology (2003) 45:242–250.
- MANTYH PW HUNT ST MAGGIO JE: Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand. Brain Res. (1984) 307:147–165.
- MANTYH PW: Neurobiology of substance P and the NK1 receptor. J. Clin. Psychiatry (2002) 63 (Suppl 1):6-10.
- OTSUKA M YOSHIOKA K: Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. (1993) 73:229–308.
- WORLD HEALTH ORGANIZATION: Disease burden measured in diabilityadjusted life years. (1990).
- NEMEROFF CB OWENS MJ: Treatment of mood disorders. Nat. Neurosci. (2002) 5(Suppl.):1068-1070.
- DIEMUNSCH P GRELOT L: Potential of substance P antagonists as antiemetics. Drugs (2000) 60:533–546.
- BOLSER DC DEGENNARO FC O'REILLY S MCLEOD RL HEY JA: Central antitussive activity of the NK1 and NK2 tachykinin receptor antagonists, CP-99,994 and SR 48968, in the guinea pig and cat. Br. J. Pharmacol. (1997) 121:165–170.
- WILLIAMSON DJ HARGREAVES RJ: Neurogenic inflammation in the context of migraine. Microsc. Res. Tech. (2001) 53:167–178.
- RUPNIAK NM KRAMER MS: Discovery of the anti-depressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. Trends Pharmacol. Sci. (1999) 20:485–490.
- KRAMER MS CUTLER N FEIGHNER J et al.: Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 281:1640–1645.